Furthermore, miRNAs also influence the interaction between CDR2L and the ribosomal protein RPS6; miR-486-5p, miR-98-5p, miR-25-3p, miR-20b-5p, and miR-16-5p, which are expressed in PCD patients, target the CDR2L and RPS6 genes, as identified through the DIANA-TarBase database of experimentally validated miRNA–gene interactions [45]. This evidence concerns the gene RPS6 and paraneoplastic neurologic syndrome.